A Humanized Mouse Model of Oral Squamous Cell Carcinoma for Investigating Resistance to Anti-PD1 Immunotherapy
Chakraborty, A. K.; Choudhury, C.; Raut, R. D.; Bais, M. V.
Show abstract
Immunotherapy has transformed cancer therapeutics; however, its impact on oral squamous cell carcinoma (OSCC) remains limited due to acquired resistance, including to Pembrolizumab. To better understand this challenge, we develop a humanized mouse model using immune-deficient NCG mice engrafted with human peripheral blood mononuclear cells (hPBMC), followed by orthotopic implantation of head and neck squamous cell carcinoma (HNSCC) stem cells. This model closely mimics the human tumor-immune microenvironment, showing aggressive tumor growth and metastasis. Pembrolizumab treatment significantly decreases CD8+ T cells, dendritic cells, and MHC-class-I expression at tumor sites, which are related to immunotherapy resistance. Further, pembrolizumab treatment confirms the elevated PD-L1 levels, immune evasion pathways and downregulation of MHC-class-I. qPCR further validates human-specific HLA expression. Our model offers a valuable tool for studying immunotherapy resistance and advancing treatment strategies in OSCC and could be useful for other cancers.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High-dimensional and spatial analysis reveals immune landscape dependent progression in cutaneous squamous cell carcinoma 94%
- Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis 93%
- Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing 92%
Similar papers in this journal
- IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models 93%
- Tumor-educated Gr1+CD11b+ cells instigate breast cancer metastasis by twisting cancer cells plasticity via OSM/IL6-JAK signaling 93%
- SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia 92%
Similar papers in this journal
- Effective Combination Immunotherapy using Oncolytic Viruses to Deliver CAR Targets to Solid Tumors 92%
- RNA-seq of Human T-Cells After Hematopoietic Stem Cell Transplantation Identifies Linc00402 as a Novel Regulator of T-Cell Alloimmunity 91%
- Personalized Medicine for Meningiomas: Drug Screening on Tumor Organoids Exposes Therapeutic Vulnerabilities to HDAC1/2i Panobinostat 91%
Similar papers in this journal
- CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts 94%
- MMP2 As An Independent Prognostic Stratifier In Oral Cavity Cancers 94%
- Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products 94%
Similar papers in this journal
- MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer 94%
- Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma 94%
- GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.